Hepatic AMPK activity is considerably diminished in NAFL and NASH (73, 74), and this is linked to the incidence of NAFLD (75), whereas AMPK activation improves NAFL and NASH (74, 76). This evidence concerns the gene PRKAA2 and metabolic dysfunction-associated steatohepatitis.